|4Jan 4, 8:53 PM ET

Catelani Michael 4

4 · Anixa Biosciences Inc · Filed Jan 4, 2023

Insider Transaction Report

Form 4
Period: 2023-01-03
Catelani Michael
President, COO & CFO
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2023-01-03+350,000350,000 total
    Exercise: $4.19Exp: 2033-01-03Common Stock (350,000 underlying)
Footnotes (2)
  • [F1]Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
  • [F2]The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2023.

Documents

1 file
  • 4
    ownership.xmlPrimary